Johnson and Johnson 2006 Annual Report Download - page 37

Download and view the complete annual report

Please find page 37 of the 2006 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 84

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84

AUDIT
The Audit Committee, comprised entirely of independent
Directors, helps the Board oversee the Company’s accounting
and reporting practices. It recommends independent public
accountants for appointment by the Board and reviews their
performance; monitors the adequacy of internal accounting
practices, procedures and controls; and reviews all significant
changes in accounting policies.
James G. Cullen, Chairman
Mary Sue Coleman, Ph.D.
Leo F. Mullin
CO M P E N S AT I O N & BENEFITS
The Compensation & Benefits Committee, comprised
entirely of independent Directors, reviews the compensa-
tion philosophy and policies of the non-Board Management
Compensation Committee with respect to executive
compensation, perquisites and other compensation matters
for employees (except for members of the Executive
Committee). The Committee also administers the Company’s
long-term incentive plans and determines the compensation
of the members of the Executive Committee. Additionally,
the Committee oversees the management of the various
retirement, pension, long-term incentive, savings, health and
welfare plans that cover substantially all employees of the
Company’s domestic operations and employees of certain
international subsidiaries.
Arnold G. Langbo, Chairman
Michael M. E. Johns, M.D.
Ann D. Jordan
Charles Prince
Steven S Reinemund
FINANCE
The Finance Committee exercises the management authority
of the Board during the intervals between Board meetings.
The Finance Committee is comprised of the Chairman,
Presiding Director and Vice Chairman of the Board.
William C. Weldon, Chairman
James G. Cullen
Christine A. Poon
NOMINAT I O N & CORPORATE GOVERNANCE
The Nominating & Corporate Governance Committee,
comprised entirely of independent Directors, is responsible
for overseeing corporate governance matters, reviewing
possible candidates for Board membership and recommending
nominees for election. The Committee is also responsible
for overseeing the process for performance evaluations of
the Board and its committees. Additionally, the Committee
reviews the Company’s management succession plans
and executive resources.
Ann D. Jordan, Chairman
James G. Cullen
Arnold G. Langbo
Charles Prince
Steven S Reinemund
PUBLIC POLICY
The Public Policy Advisory Committee reviews the Company’s
policies, programs and practices on public health issues
regarding the environment and the health and safety
of employees. The Committee also reviews the Company’s
governmental affairs and policies and other public policy
issues facing the Company. The Committee advises and makes
recommendations to the Board on these issues as appropriate.
The Public Policy Advisory Committee is comprised of
independent Directors and the Company’s General Counsel
and Vice Presidents for Corporate Affairs and Government
Affairs and Policy.
Leo F. Mullin, Chairman
Russell C. Deyo
Thomas M. Gorrie, Ph.D.
Susan L. Lindquist, Ph.D.
Brian D. Perkins
David Satcher, M.D., Ph. D.
SCIENCE & TECHNOLOGY
The Science & Technology Advisory Committee is comprised
of independent Directors and the Company’s Vice President,
Science and Technology. It advises the Board on scientific
matters, including major internal projects, interaction
with academic and other outside research organizations,
and the acquisition of technologies and products.
David Satcher, M.D., Ph.D., Chairman
Mary Sue Coleman, Ph.D.
Michael M. E. Johns, M.D.
Susan L. Lindquist, Ph.D.
Theodore J. Torphy, Ph.D.
B O A R D O F D I R E C T O R S A N D C O M M I T T E E S O F T H E B O A R D
Committees
of the Board
35